Contract facts
UnrestrictedNo full NAICS 325412 intel page yet. Browse NAICS intelligence
Radiopharmaceutical Supplies-Netspot (GALLIUM 68 DOTATATE) is a federal Unrestricted award for 262-Network Contract Office 22 (36C262) held by Jubilant Draximage Radiopharmacies, Inc. Estimated value $520K ($520K obligated). Current period of performance ends Jul 21, 2027 (potential Jul 31, 2027). Last award drew 2 bidders. Place of performance: LOMA LINDA CA.
Radiopharmaceutical supplies-netspot (gallium 68 dotatate). Latest action is a modification.
Recompete timing
PublicCurrent PoP ends Jul 21, 2027 (252 days remaining). Agencies typically plan 12–18 months ahead — at 8.3 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on 36C26222C0145? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordJubilant Draximage Radiopharmacies, Inc — $14.3M obligated across 85 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C26222C0145?
36C26222C0145 (Radiopharmaceutical supplies-netspot (gallium) is a 262-Network Contract Office 22 (36C262) award with a potential value of $520K, currently held by Jubilant Draximage Radiopharmacies, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C262-22-C-0145?
36C262-22-C-0145 is the dashed form of contract 36C26222C0145 (Radiopharmaceutical supplies-netspot (gallium), held by Jubilant Draximage Radiopharmacies, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C26222C0145?
262-Network Contract Office 22 (36C262) awarded 36C26222C0145 to Jubilant Draximage Radiopharmacies, Inc (potential $520K).
Who is the incumbent on 36C26222C0145?
Jubilant Draximage Radiopharmacies, Inc is the incumbent with $14.3M across 85 related awards in SCOUT’s public footprint. The current period of performance ends Jul 21, 2027.
When does Jubilant Draximage Radiopharmacies, Inc’s 36C26222C0145 come up for recompete?
SCOUT tracks a period-of-performance end of Jul 21, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 36C26222C0145? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by contract number; task orders appear as independent rows.